Suzhou Yixi Biotechnology
Yixi Biotech is an intestinal microbial gene modification technology platform
At a glance
- Status
- Operational
- Open positions
- None listed
- Dealroom signal
- 16.0/100
- Industry
- Health
- Sub-industry
- Pharmaceutical, BioTechnology
- Sector
- Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
- Links
- Website
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Aug 2025 | — | — | Undisclosed | ↗ |
| SEED✓Equity / VC | Aug 2023 | $14M | $55M | Huangpu Biotech · Shenzhen Gaoxin Investment · Vitalbridge Capital · Clivia Capital | ↗ |
Growth signals
Latest recorded traffic for Suzhou Yixi Biotechnology is 820 monthly website visits, up 1266.7% over the last three months.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Suzhou Yixi Biotechnology in its local ecosystem
The Suzhou Yixi Biotechnology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed7 investors entered at this stage
- HBHuangpu Biotech
- SIShenzhen Gaoxin Investment
Vitalbridge Capital
Clivia Capital- NFNanwan Baiao Fund
- SMSichuan Yizhan Capital Management
Oriza Holdings
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Suzhou Yixi Biotechnology on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Suzhou Yixi Biotechnology’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









